Table 3 Prevalence of qualitative CTE findings according to endoscopic severity of ileocolonic lesions
From: CT enterography for evaluation of disease activity in patients with ileocolonic Crohn's disease
Normal mucosa | Non-ulcerative lesions | Ulceration | Active disease at endoscopy (CDEIS ≥ 3) | |
|---|---|---|---|---|
No(N = 280) | 98 | 61 | 121 | 174 |
Mural stratification | 6 (6.1%) | 24 (39.3%) | 99 (81.8%) | 122 (70.1%) |
Ulceration | 3 (3.1%) | 12 (19.7%) | 78 (64.5%) | 89 (51.1%) |
Polyp | 2 (2.0%) | 13 (21.3%) | 22 (18.2%) | 35 (20.1%) |
Submucosal fat deposition | 1 (1.0%) | 3 (4.9%) | 6 (5.0%) | 9 (5.2%) |
Sacculation of antimesenteric wall | 0 | 3 (4.9%) | 4 (3.3%) | 7 (4.0%) |
Perienteric fat hypertrophy | 1 (1.0%) | 3 (4.9%) | 12 (9.9%) | 15 (8.6%) |
Perienteric fat stranding | 2 (2.0%) | 9 (14.8%) | 54 (44.6%) | 63 (36.2%) |
Comb sign | 1 (1.0%) | 2 (3.3%) | 35 (28.9%) | 37 (21.3%) |